Tax
Tax Reconciliation, Tax Credits
Vertex Pharmaceuticals Tax Reconciliation, Tax Credits remained flat by 0.0% to $0.26 in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 1615.0%, from $0.02 to $0.26. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionTax
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ4 2024Feb 13, 2026
How to read this metric
An increase indicates higher utilization of tax incentives, which lowers the effective tax rate.
Detailed definition
Represents the specific tax credit adjustments that reduce the total income tax expense relative to the statutory corpor...
Peer comparison
Commonly reported by large financial institutions as part of the effective tax rate reconciliation.
Metric ID:
cop_tax_reconciliation_tax_creditsHistorical Data
2 years
| FY'23 | FY'24 | |
|---|---|---|
| Value | $0.06 | $1.03 |
| YoY Change | — | >999% |
Range$0.06 – $1.03
Avg YoY Growth>999%
Median YoY Growth>999%
Tax Reconciliation, Tax Credits at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's tax reconciliation, tax credits?
- Vertex Pharmaceuticals (VRTX) reported tax reconciliation, tax credits of $0.26 in Q4 2024.
- How has Vertex Pharmaceuticals's tax reconciliation, tax credits changed year-over-year?
- Vertex Pharmaceuticals's tax reconciliation, tax credits increased by 1615.0% year-over-year, from $0.02 to $0.26.
- What does tax reconciliation, tax credits mean?
- The total value of tax credits applied to reduce the company's income tax liability.